No Data
Is Kiniksa Pharmaceuticals International, Plc (KNSA) the Best Small Cap Pharma Stocks to Buy Now?
Evercore Maintains Kiniksa Pharmaceuticals International(KNSA.US) With Buy Rating, Maintains Target Price $35
Goldman Sachs Maintains Kiniksa Pharmaceuticals International(KNSA.US) With Buy Rating, Maintains Target Price $32
Goldman Sachs Initiates Kiniksa Pharmaceuticals International(KNSA.US) With Buy Rating, Announces Target Price $32
Wells Fargo Maintains Kiniksa Pharmaceuticals International(KNSA.US) With Buy Rating, Cuts Target Price to $30
Kiniksa Issues Updates on Abiprubart, KPL-387, Mavrilimumab
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}